Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
1034.5000 -2.40 (-0.23%)
NSE Sep 16, 2025 15:31 PM
Volume: 511.7K
 

logo
Zydus Lifesciences Ltd.
16 Aug 2018, 03:40PM
1034.50
-0.23%
buy
by HDFC Securities
HDFC Securities
Revenue fell by 12.18% to Rs. 2768.7 Cr in Q1FY19 when compared to the previous quarter. Cadila Healthcare Ltd Q1FY19 results Comment
 
Zydus Lifesciences L.. has an average target of 1045.33 from 6 brokers.
More from Zydus Lifesciences Ltd.
Recommended
Five stocks to buy from analysts this week - September 16, 2025
The Baseline | 16 Sep 2025, 06:08PM
Market closes higher, JSW Infrastructure signs a Rs 740 crore agreement with SMPK
Trendlyne Marketwatch | 16 Sep 2025, 03:55PM
Earnings Call Transcript - Cadila Healthcare
| 14 Feb 2020